These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 19408176

  • 1. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC, Coutinho EM, Oladapo L, Noronha CF, Mota RL, Lopes AC, Lopes RC.
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [Abstract] [Full Text] [Related]

  • 2. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 3. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 4. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML, Thomas JL, Bergougnoux L, Garnero P, Drapier-Faure E, Delmas PD.
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S, D'Agosta S, Lombardo G.
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [Abstract] [Full Text] [Related]

  • 6. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
    Demir B, Ozturkoglu E, Solaroglu A, Baskan B, Kandemir O, Karabulut E, Haberal A.
    Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
    [Abstract] [Full Text] [Related]

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 8. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ.
    Fertil Steril; 2006 Apr; 85(4):979-88. PubMed ID: 16580384
    [Abstract] [Full Text] [Related]

  • 9. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J, Travica S, Metka M, Pietschmann P.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1035-43. PubMed ID: 10677891
    [Abstract] [Full Text] [Related]

  • 10. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL.
    Menopause; 2005 Dec 23; 12(6):716-27. PubMed ID: 16278615
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A.
    Maturitas; 2004 Aug 20; 48(4):456-62. PubMed ID: 15283939
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.
    Westhoff C, Kaunitz AM, Korver T, Sommer W, Bahamondes L, Darney P, Verhoeven C.
    Obstet Gynecol; 2012 May 20; 119(5):989-99. PubMed ID: 22525910
    [Abstract] [Full Text] [Related]

  • 13. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 14. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S, Carranza-Lira S, Celis-Gonzalez C, Santoyo S, Murillo A, Martinez N, Santos J, Llaca V, de la Loza FR, Zarain J, da Fonseca AM, Camargos AF, Baracat EC, da Sá MF, Bayo J, Adaro L, Gurucharri C, Murga M, Siseles N, Sayegh F, Tempone A, Tempone LM, Tozzini RI, Boccanera R, Naranjo C, Sanchez F, Gomez G, Blanco S, Reyes-Marquez R, Albrecht G, Rios PC.
    Maturitas; 2005 Mar 14; 50(3):189-95. PubMed ID: 15734600
    [Abstract] [Full Text] [Related]

  • 15. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec 14; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 16. [Effects of a 19-norprogesterone derivative, the fourth decade nomegestrol acetate, on lipids].
    Pélissier C, Jamin C, Colau JC.
    Ann Endocrinol (Paris); 2003 Jun 14; 64(3):216-26. PubMed ID: 12910065
    [Abstract] [Full Text] [Related]

  • 17. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J, Hammar M.
    Maturitas; 2005 Apr 11; 50(4):344-52. PubMed ID: 15780536
    [Abstract] [Full Text] [Related]

  • 18. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH, Speroff L, Ellman H, Dart C.
    Menopause; 2005 Apr 11; 12(6):708-15. PubMed ID: 16278614
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun 11; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 20. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ.
    Gynecol Endocrinol; 2001 Oct 11; 15(5):349-58. PubMed ID: 11727357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.